Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 5/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PLK1 | P53350 | 1/20 | 0.30 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.30 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22451337 | 0.93 | APP (0.35) | APPNPC1RAB9APOLBPLK1 | |
| SCHEMBL22451177 | 0.91 | TSHR (0.34) | APPNPC1RAB9APOLBPLK1 | |
| SCHEMBL22451365 | 0.89 | ALDH1A1 (0.35) | APPNPC1RAB9APOLBPLK1 | |
| SCHEMBL24345953 | 0.89 | NPC1 (0.35) | NPC1RAB9APOLBPLK1ALDH1A1 | |
| SCHEMBL22451353 | 0.86 | TSHR (0.37) | NPC1RAB9APOLBPLK1ALDH1A1 | |
| SCHEMBL21261974 | 0.86 | NPC1 (0.39) | NPC1RAB9APOLBPLK1 | |
| SCHEMBL21262068 | 0.86 | NPC1 (0.39) | NPC1RAB9APOLBPLK1 | |
| SCHEMBL22451258 | 0.86 | NPC1 (0.39) | NPC1RAB9APOLBPLK1 | |
| SCHEMBL19199350 | 0.86 | NPC1 (0.39) | NPC1RAB9APOLBPLK1 | |
| SCHEMBL22451251 | 0.86 | NPC1 (0.33) | NPC1RAB9APOLBPLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795151-B2 | Benzotriazole compound | MIYOSHI OIL & FAT CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20200325107-A1 | BENZOTRIAZOLE COMPOUND | MIYOSHI OIL & FAT CO., LTD. (JP) | 2020-10-15 | — | — | US | disclosed |
| EP-3712138-A1 | BENZOTRIAZOLE COMPOUND | Miyoshi Oil & Fat Co., Ltd. (JP) | 2020-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795151-B2 | Benzotriazole compound | PRXL2A, HAX1, XRN2 | APP 1346/4885NPC1 4465/4885RAB9A 3572/4885 |
| US-20200325107-A1 | BENZOTRIAZOLE COMPOUND | PRXL2A, HAX1, XRN2 | APP 1346/4885NPC1 4465/4885RAB9A 3572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.